Researcher Bios



 

 

 



J
oachim Kohn, PhD        
Director, RCCC 
Rutgers, the State University of New Jersey  
Director, New Jersey Center for Biomaterials (njbiomaterials.org)
Board of Governors Professor, Department of Chemistry and Chemical Biology
Adjunct Associate Professor of Orthopaedics, New Jersey Medical School

JOACHIM KOHN is a pioneer in the use of combinatorial and computational methods for the optimization of biomaterials for specific medical applications and is known for his seminal work on "pseudo-poly(amino acid)s". He has published more than 200 scientific manuscripts, holds 40 patents, has spun-off three start-up companies, and has twice received the annual Thomas Alva Edison Patent Award for best patent in New Jersey.  

Back to top

 

Linda M. Graham, MD
Deputy Director, RCCC 
 
Cleveland Clinic

Department of Vascular Surgery
Department of Biomedical Engineering
Professor of Surgery, Cleveland Clinic Lerner College of Medicine of Case Western Reserve
University


LINDA M. GRAHAM is a practicing vascular surgeon with an active research laboratory. Her NIH-funded research focuses on vascular wall biology and graft healing. She has developed methods to seed cells onto prosthetic scaffolds to produce tissue lined vascular grafts. She has published over 100 journal articles and book chapters.


Back to top

 


 

Joseph M. Rosen, MD
Chief Medical Officer, RCCC

Dartmouth College/Hitchcock Medical Center
Professor of Surgery, Division of Plastic Surgery
Adjunct Associate Professor and Senior Lecturer, Thayer School of Engineering at Dartmouth
Chair of IED Task Force Medical Sub-Panel, Defense Science Board

JOSEPH M. ROSEN has practiced reconstructive plastic surgery for 30 years, specializing in hand surgery and microsurgery, and is also highly regarded for his facial reconstruction work. He has served wounded service people at Walter Reed National Military Medical Center in this capacity during the current wars. His other research interests include human machine interfaces, microsurgery and transplantation of limbs, computer-aided surgery, and surgical education.

Back to top



Daniel G. Anderson, PhD
Massachusetts Institute of Technology    
Research Associate, David H. Koch Institute for Integrative Cancer Research (http://web.mit.edu/ki/)
 
DANIEL G. ANDERSON pioneered the use of robotic methods for the development of smart biomaterials for drug delivery and tissue engineering.  He has developed robotic technology that allows rapid synthesis, formulation, analysis, and biological testing of large libraries of biomaterials for use in medical devices, cell therapy and drug delivery, resulting in publication of over 80 papers and pending patents.

Back to top

Steven T. Boyce, PhD
University of Cincinnati
Professor, Department of Surgery, College of Medicine
Adjunct Professor, Department of Biomedical Engineering, College of Engineering
Senior Investigator, Research Department Shriners Burns Hospital, Cincinnati, Ohio

STEVEN BOYCE has made numerous discoveries which have led to regulated growth of skin cells in combination with degradable biopolymer implants. Preclinical studies based on his work have demonstrated formation of skin barrier and blood vessels, and restoration of pigmentation. Dr. Boyce has also received numerous patents, and founded two start-up companies.

Back to top

Richard A. F. Clark, MD
Stony Brook University 
Director, Center of Tissue Engineering
Professor, Department of Biomedical Engineering, Dermatology
Adjunct Professor, Department of Medicine
  
RICHARD A. F. CLARK has extensive experience in wound healing and skin disorders.  He has made seminal observations regarding the sources and significance of fibronectin protein in wounds and wound healing, including the discovery of bioactive peptides within the fibronectin structure that enhance the activity of growth factors and act as survival factors for tissue cells. Dr. Clark is the scientific founder of two start-up companies. 

Back to top

 Kathleen A. Derwin, PhD
Cleveland Clinic
Assistant Staff, Department of Biomedical Engineering, Lerner Research Institute, and Joint Appointee, Department of Orthopaedic Surgery
Assistant Professor, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University
Adjunct Assistant Professor, Department of Biomedical Engineering, Case Western Reserve University

KATHLEEN A. DERWIN’s research focuses on various aspects of understanding the causes and improving the treatment of musculoskeletal soft tissue injuries. Her multidisciplinary team has developed natural, mechanically robust extracellular matrix scaffolds for rotator cuff repair, novel model systems for evaluating scaffold-based technologies, and real-time imaging techniques for quantifying the progression of healing in living systems.

Back to top
               
Michael G. Dunn, PhD
University of Medicine and Dentistry of New Jersey
Robert Wood Johnson Medical School
Associate Professor of Orthopaedic Surgery and Founding Director, Orthopaedic Research Laboratories
Faculty Member, Rutgers-UMDNJ Joint Graduate Program in Biomedical Engineering

MICHAEL G. DUNN’s principal research interests are in tissue engineering approaches for regeneration and reconstruction of musculoskeletal soft tissues. His collaborations with Dr. Gatt focus on polymer and collagen scaffolds for ligament and meniscus implants.

Back to top

Charles J. Gatt, MD
University of Medicine and Dentistry of New Jersey
Chairman, Department of Orthopaedic Surgery,
Adjunct Faculty, School of Biomedical Engineering, Rutgers University, New Brunswick, New Jersey

CHARLES J. GATT, JR. is an orthopaedic surgeon specializing in sports medicine. Dr. Gatt’s research interests include tissue engineering and allograft (grafts from other individuals) science, including development of scaffolds for the treatment of ligament and meniscal injuries. His work has evaluated the effects of donor age and gender on mechanical properties of allografts and the effects of growth factors on allograft incorporation.

Back to top

Stanton L. Gerson, MD
Case Western Reserve University    
Asa and Patricia Shiverick Professor
Director of the Case Comprehensive Cancer Center and Ireland Cancer Center
Director of the Ohio Wright Center for Stem Cell and Regenerative Medicine at Case School of Medicine and University Hospitals Case Medical Center, Cleveland, Ohio

Dr. Gerson has been active in developing therapeutic programs that use stem cells to treat hematologic malignancies. His research interests are in the areas of stem cells and DNA repair. His research has generated seven patents in the area of gene therapy and cancer drug development that have been licensed to three companies.

Back to top

Linda G. Griffith, PhD
Massachusetts Institute of Technology
Director of MIT Biotech/Pharma Engineering Center
School of Engineering Teaching Innovation Professor
Department of Biological Engineering and Department of Mechanical Engineering

LINDA G. GRIFFITH conducts research in biomaterials and devices for tissue and organ regeneration combining molecular design and synthesis of biomaterials with design and synthesis of macroscopic 3-D devices for therapeutic and in vitro use. Dr. Griffith, a MacArthur Foundation Fellow, is a co-founder of Therics, Inc. and has served as consultant or advisory board member for several tissue engineering and pharmaceutical companies.

Back to top

Scott A. Guelcher, PhD
Vanderbilt University    
Assistant Professor, Department of Chemical Engineering

SCOTT A. GUELCHER’s research interests are in the design and development of biodegradable polyurethane scaffolds, composites, and delivery systems for bone regeneration to meet the needs of the targeted clinical application. His research team has prepared biomaterials with enhanced biological and mechanical properties by combining the polymers with allograft bone, growth factors, and antibiotics. He is a co-inventor on 15 US patents and pending applications.

Back to top

   
Jeffrey O. Hollinger, DDS, PhD
Carnegie Mellon University
Director, Bone Tissue Engineering Center
Professor, Biomedical Engineering Department

JEFFREY O. HOLLINGER’s research interests are in bone regeneration, including regeneration of osseous components of the cranio-mandibular facial complex. He is also engaged with several industrial groups that emphasize bone regenerative therapeutics. Dr. Hollinger has over 250 peer-reviewed publications, abstracts, book chapters and books. He retired in 1993 from the US Army as a Colonel after serving 20 years of active duty.

Back to top

Adam J. Katz, MD, FACS
University of Florida
Associate Professor, Division of Plastic and Reconstructive Surgery
Director of Plastic Surgery Research
Director of Clinical Trials, Department of Surgery

ADAM J. KATZ is a clinically active plastic surgeon. Dr. Katz helped pioneer the conception, detection, description, and early characterization of multipotent stem cells derived from human adipose tissue, while a surgical resident at University of Pittsburgh Medical Center. Dr. Katz is the author of multiple issued and pending patents related to adipose-derived cells, and has helped found several companies based on university research.

Back to top

Robert S. Langer, ScD
Massachusetts Institute of Technology
Germeshausen Professor of Chemical and Biomedical Engineering, Department of Chemical Engineering

ROBERT S. LANGERS’s research interests includes drug delivery, biotechnology, immobilized enzymes, and biomedical engineering. His specialty is the study and development of polymers to deliver drugs, particularly genetically engineered proteins and DNA. Among Dr. Langer's more than 300 active and more than 300 pending patents, many have been licensed or sublicensed to over 220 pharmaceutical, chemical, biotechnology and medical device companies.

Back to top

Thomas A. Mustoe, MD
Northwestern University
Professor and Chief, Division of Plastic Surgery
Feinberg School of Medicine Professor
Director of Wound Healing Research Laboratory

THOMAS A. MUSTOE’s research involves wound healing with a focus on utilizing animal models to elucidate basic mechanisms of healing and scarring. He has also had multiple collaborations with biotechnology and pharmaceutical companies and carried out FDA sponsored clinical trials in scarring and wound healing. He has co-authored more than 150 peer-reviewed papers, with multiple chapters, and invited articles; he also has an active clinical practice.

Back to top

George F. Muschler, MD
Cleveland Clinic
Staff Surgeon, Department of Orthopaedic Surgery
Director, Orthopaedic Research Center and the Clinical Tissue Engineering Center (www.ctecohio.org)
Vice-Chairman, Department of Biomedical Engineering
Vice-Chairman for Research, Orthopaedic and Rheumatologic Institute

GEORGE F. MUSCHLER specializes in reconstructive Orthopaedic Surgery and has devoted his career to advancing patient care through basic and clinical research. His primary research areas are the harvest, processing and transplantation of adult connective tissue stem cells and progenitor cells (CTPs) for treatment of fractures and problems of degenerative joints; the effects of aging and osteoporosis on CTPs; and optimizing assays for CTPs and other stem cells.

Back to top



Timur P. Sarac, MD
Cleveland Clinic
Staff Vascular Surgeon, Cleveland Clinic Department of Vascular Surgery
Associate Professor, Cleveland Clinic Lerner College of Medicine, Case Western Reserve University

TIMUR P. SARAC is a surgeon and the inventor of tissue lined stent technology among several vascular technologies. He is a retired Major in the United States Army Reserves and was awarded an Achievement Medal during Operation Iraqi Freedom /Enduring Freedom for his innovative endovascular treatment of injured soldiers.

Back to top

Maria Z. Siemionow, MD, PhD
Cleveland Clinic
Director, Plastic Surgery Research, Department of Plastic Surgery
Head, Microsurgery Training, Microsurgery Laboratory of the Department of Plastic Surgery
Professor of Surgery, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH

MARIA SIEMIONOW is an expert surgeon with interests and expertise including microsurgery, hand surgery, peripheral nerve surgery, transplantation, and microcirculation. Her research focuses on conducting composite tissue allograft transplantation without the need for lifelong immunosuppression. She was the first physician in the world to receive institutional approval for composite facial allograft (donor graft) transplantation surgery.

Back to top


Cathryn A. Sundback, PhD
Massachusetts General Hospital/Harvard University
Director, Laboratory for Tissue Engineering and Organ Fabrication

CATHRYN SUNDBACK’s research focuses on the application of biomaterials for tissue engineering of limb tissues, particularly peripheral nerve, skeletal muscle, and bone. She has developed neural guidance conduits to repair peripheral nerve injuries with improved return of function, resulting in numerous publications and pending patents. She is currently developing clinically translatable models to engineer functional skeletal muscle tissue and vascularized bone.

Back to top

Joseph P. Vacanti, MD
Massachusetts General Hospital/Harvard University
John Homans Professor of Surgery
Chief, Department of Pediatric Surgery, Massachusetts General Hospital (MGH)
Surgeon-in-Chief, MGH Hospital for Children  
Co-Director, Center for Regenerative Medicine, MGH
Director, Laboratory for Tissue Engineering and Organ Fabrication, MGH
Chief, Pediatric Transplantation, MGH

JOSPEH P. VACANTI  has been working in the field of tissue engineering since its beginnings in the early 1980s - a mission that stems from his long-held interest in solving the problem of organ shortages. His approach to regenerating tissues involves a scaffold made of an artificial, biodegradable polymer, seeding it with living cells, and bathing it in growth factors. He has authored over 265 original reports, 62 book chapters and over 430 abstracts. Dr. Vacanti has 75 patents or patents pending in the United States, Canada, Europe, and Japan.

Back to top

Anthony Windebank, MD
Mayo Clinic  
Professor of Neurology, Mayo Medical School

ANTHONY WINDEBANK’s major areas of research are repair and regeneration after spinal cord injury, stem cell treatment of motor neuron disease, and the mechanism of neuronal cell death caused by chemotherapeutic agents. His approach includes studies of both animal and tissue culture models of neuronal death and regeneration.

Back to top


Michael J. Yaszemski, MD, PhD, Brig Gen USAF
Mayo Clinic  
Professor of Orthopedics and Biomedical Engineering
Director, Tissue Engineering and Biomaterials Laboratory

MICHAEL J. YASZEMSKI‘s clinical practice encompasses spinal surgery, with a focus on the resection and reconstruction of spino-pelvic tumors. His research interests are in the synthesis and characterization of novel degradable polymers for use in bone, cartilage, and neural tissue regeneration. From July to September 2006, he deployed as Deputy Commander, 332nd Medical Group at the Air Force Theater Hospital in Balad, Iraq.

Back to top